Mutational Status of Myeloproliferative Neoplasms
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2010)
Journal
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
Volume 20, Issue 1, Pages 61-76Publisher
BEGELL HOUSE INC
Keywords
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Pathogenic germline variants associated with myeloproliferative disorders in apparently normal individuals: Inherited or acquired genetic alterations?
Reiner A. Veitia, Hideki Innan
CLINICAL GENETICS (2022)
Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms
Jean Pegliasco, Pierre Hirsch, Christophe Marzac, Francoise Isnard, Jean-Come Meniane, Caroline Deswarte, Philippe Pellet, Celine Lemaitre, Gwendoline Leroy, Graciela Rabadan Moraes, Helene Guermouche, Barbara Schmaltz-Panneau, Florence Pasquier, Chrystelle Colas, Patrick R. Benusiglio, Odile Bera, Jean-Henri Bourhis, Eolia Brissot, Olivier Caron, Samy Chraibi, Pascale Cony-Makhoul, Christine Delaunay-Darivon, Simona Lapusan, Flore Sicre de Fontbrune, Pascal Fuseau, Albert Najman, William Vainchenker, Francois Delhommeau, Jean-Baptiste Micol, Isabelle Plo, Christine Bellanne-Chantelot
LEUKEMIA (2022)
Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
Tatiana Makarik, Adhamjon O. Abdullaev, Elena E. Nikulina, Svetlana A. Treglazova, Elena E. Stepanova, Irina N. Subortseva, Alla M. Kovrigina, Anait L. Melikyan, Sergei M. Kulikov, Andrey B. Sudarikov
GENES (2021)
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
Giuseppe G. Loscocco, Giacomo Coltro, Paola Guglielmelli, Alessandro M. Vannucchi
CELLS (2021)
Hematoxylin binds to mutant calreticulin and disrupts its abnormal interaction with thrombopoietin receptor
Ruochen Jia, Thomas Balligand, Vasyl Atamanyuk, Harini Nivarthi, Erica Xu, Leon Kutzner, Jakob Weinzierl, Audrey Nedelec, Stefan Kubicek, Roman Lesyk, Oleh Zagrijtschuk, Stefan N. Constantinescu, Robert Kralovics
BLOOD (2021)
Comparison of Clinical and Hematological Parameters of Janus Kinase 2, Calreticulin or Myeloproliferative Leukemia Virus Oncogene Mutant Essential Thrombocythemia and Triple-Negative Essential Thrombocythemia
Jale Yildiz, Hikmettullah Batgi
CUREUS JOURNAL OF MEDICAL SCIENCE (2022)
Comparison of Clinical and Molecular Features Between Patients With Essential Thrombocythemia and Early/Prefibrotic Primary Myelofibrosis Presenting With Thrombocytosis in Taiwan
Ming-Chung Kuo, Wen-Yu Chuang, Hung Chang, Tung-Huei Lin, Jin-Hou Wu, Tung-Liang Lin, Che-Wei Ou, Yu-Shin Hung, Ting-Yu Huang, Ying-Jung Huang, Po-Nan Wang, Lee-Yung Shih
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2023)
Sequential Development of JAK2V617F Mutation and BCR-ABL1 Fusion in Individual Patients With Myeloproliferative Neoplasms A Linear Clonal Evolution or Parallel Clonal Competition?
Yue Zhao, Deepti Reddi, Jenna McCracken, Natasha Iranzad, Cathrine Rehder, Jadee Neff, Endi Wang
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2022)
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Juan Carlos Hernandez-Boluda, Diderik-Jan Eikema, Linda Koster, Nicolaus Kroeger, Marie Robin, Moniek de Witte, Juergen Finke, Maria Chiara Finazzi, Annoek Broers, Ludek Raida, Nicolaas Schaap, Patrizia Chiusolo, Mareike Verbeek, Carin L. E. Hazenberg, Kazimierz Halaburda, Aleksandr Kulagin, Helene Labussiere-Wallet, Tobias Gedde-Dahl, Werner Rabitsch, Kavita Raj, Joanna Drozd-Sokolowska, Giorgia Battipaglia, Nicola Polverelli, Tomasz Czerw, Ibrahim Yakoub-Agha, Donal P. Mclornan
BONE MARROW TRANSPLANTATION (2023)
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis
Mattheus H. E. Wildschut, Julien Mena, Cyril Dordelmann, Marc van Oostrum, Benjamin D. Hale, Jens Settelmeier, Yasmin Festl, Veronika Lysenko, Patrick M. Schurch, Alexander Ring, Yannik Severin, Michael S. Bader, Patrick G. A. Pedrioli, Sandra Goetze, Audrey van Drogen, Stefan Balabanov, Radek C. Skoda, Massimo Lopes, Bernd Wollscheid, Alexandre P. A. Theocharides, Berend Snijder
NATURE COMMUNICATIONS (2023)
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
Kotaro Shide, Katsuto Takenaka, Akira Kitanaka, Akihiko Numata, Takuro Kameda, Takuji Yamauchi, Atsushi Inagaki, Shohei Mizuno, Akiyoshi Takami, Shinichi Ito, Masao Hagihara, Kensuke Usuki, Takaaki Maekawa, Kazutaka Sunami, Yasunori Ueda, Miyuki Tsutsui, Miki Ando, Norio Komatsu, Keiya Ozawa, Mineo Kurokawa, Shunya Arai, Kinuko Mitani, Koichi Akashi, Kazuya Shimoda
ANNALS OF HEMATOLOGY (2023)
Germline-somatic JAK2 interactions are associated with clonal expansion in myelofibrosis
Derek W. Brown, Weiyin Zhou, Youjin Wang, Kristine Jones, Wen Luo, Casey Dagnall, Kedest Teshome, Alyssa Klein, Tongwu Zhang, Shu-Hong Lin, Olivia W. Lee, Sairah Khan, Jacqueline B. Vo, Amy Hutchinson, Jia Liu, Jiahui Wang, Bin Zhu, Belynda Hicks, Andrew St Martin, Stephen R. Spellman, Tao Wang, H. Joachim Deeg, Vikas Gupta, Stephanie J. Lee, Neal D. Freedman, Meredith Yeager, Stephen J. Chanock, Sharon A. Savage, Wael Saber, Shahinaz M. Gadalla, Mitchell J. Machiela
NATURE COMMUNICATIONS (2022)
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
Tamara K. Moyo, Ashwin Kishtagari, Matthew T. Villaume, Brandon McMahon, Sanjay R. Mohan, Tess Stopczynski, Sheau-Chiann Chen, Run Fan, Yuankai Huo, Hyeonsoo Moon, Yucheng Tang, Cosmin A. Bejan, Merrida Childress, Ingrid Anderson, Kyle Rawling, Rhea M. Simons, Ashley Moncrief, Rebekah Caza, Laura Dugger, Aunshka Collins, Channing Dudley, P. Brent Ferrell, Michael Byrne, Stephen A. Strickland, Gregory D. Ayers, Bennett A. Landman, Emily F. Mason, Ruben A. Mesa, Jeanne M. Palmer, Laura C. Michaelis, Michael R. Savona
CLINICAL CANCER RESEARCH (2023)
Bleeding diathesis in mice lacking JAK2 in platelets
Nathan Eaton, Saravanan Subramaniam, Marie L. Schulte, Caleb Drew, David Jakab, Sandra L. Haberichter, Hartmut Weiler, Herve Falet
BLOOD ADVANCES (2021)
Antibody targeting of mutant calreticulin in myeloproliferative neoplasms
Frederike Kramer, Ann Mullally
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2023)
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Livio Pagano, Jon Salmanton-Garc, Francesco Marchesi, Alberto Lopez-Garcia, Sylvain Lamure, Federico Itri, Maria Gomes-Silva, Giulia Dragonetti, Iker Falces-Romero, Jaap van Doesum, Uluhan Sili, Jorge Labrador, Maria Calbacho, Yavuz M. Bilgin, Barbora Weinbergerova, Laura Serrano, Jose-Maria Ribera-Santa Susana, Sandra Malak, Jose Loureiro-Amigo, Andreas Glenthoj, Raul Cordoba-Mascunano, Raquel Nunes-Rodrigues, Tomas-Jose Gonzalez-Lopez, Linda Katharina Karlsson, Maria-Josefa Jimenez-Lorenzo, Jose-Angel Hernandez-Rivas, Ozren Jaksic, Zdenek Racil, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Nikolai Klimko, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Oliver A. Cornely
BLOOD (2022)
Genetic and phenotypic attributes of splenic marginal zone lymphoma
Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, Lodovico Terzi di Bergamo, Martin Faderl, Valeria Spina, Adalgisa Condoluci, Luisella Bonomini, Gabriela Forestieri, Ricardo Koch, Deborah Piffaretti, Katia Pini, Maria Cristina Pirosa, Micol Giulia Cittone, Alberto Arribas, Marco Lucioni, Guido Ghilardi, Wei Wu, Luca Arcaini, Maria Joao Baptista, Gabriela Bastidas, Silvia Bea, Renzo Boldorini, Alessandro Broccoli, Marco Matteo Buehler, Vincenzo Canzonieri, Luciano Cascione, Luca Ceriani, Sergio Cogliatti, Paolo Corradini, Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaidano, Juan Fernando Garcia, Bernhard Gerber, Paolo Ghia, Maria Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Inghirami, Marco Ladetto, Armando Lopez-Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Veronique Meignin, Michele Merli, Alden Moccia, Manuela Mollejo, Carlos Montalban, Urban Novak, David Graham Oscier, Francesco Passamonti, Francesco Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Salles, Elisa Santambrogio, Lydia Scarfo, Anastasios Stathis, Georg Stussi, Julia T. Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thieblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elias Campo, Laurence De Leval, Stefan Dirnhofer, Stefano A. Pileri, Miguel A. Piris, Alexandra Traverse-Glehen, Alexander Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi
BLOOD (2022)
The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence
Francesco Passamonti, Giovanni Corrao, Gastone Castellani, Barbara Mora, Giulia Maggioni, Robert Peter Gale, Matteo Giovanni Della Porta
BLOOD REVIEWS (2022)
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation
Marco Salvini, Fabrizio Maggi, Camilla Damonte, Lorenzo Mortara, Antonino Bruno, Barbara Mora, Marco Brociner, Roberta Mattarucchi, Alessia Ingrassia, Davide Sirocchi, Benedetta Bianchi, Stefania Agnoli, Matteo Gallazzi, Michele Merli, Andrea Ferrario, Raffaella Bombelli, Daniela Barraco, Andreina Baj, Lorenza Bertu, Paolo A. Grossi, Francesco Passamonti
BONE MARROW TRANSPLANTATION (2022)
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report
Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, Immacolata Attolico, Sara Barulli, Micaela Bergamaschi, Gianni Binotto, Monica Bocchia, Massimiliano Bonifacio, Giovanni Caocci, Isabella Capodanno, Fausto Castagnetti, Francesco Cavazzini, Elena Crisa, Monica Crugnola, Maria Stella De Candia, Chiara Elena, Carmen Fava, Sara Galimberti, Antonella Gozzini, Gabriele Gugliotta, Tamara Intermesoli, Alessandra Iurlo, Gaetano La Barba, Roberto Latagliata, Sabrina Leonetti Crescenzi, Luciano Levato, Giuseppina Loglisci, Alessandro Lucchesi, Luigiana Luciano, Francesca Lunghi, Debora Luzi, Alessandra Malato, Maria Cristina Miggiano, Michele Pizzuti, Patrizia Pregno, Davide Rapezzi, Giovanna Rege-Cambrin, Gianantonio Rosti, Sabina Russo, Rosaria Sancetta, Anna Rita Scortechini, Federica Sora, Paolo Sportoletti, Fabio Stagno, Agostino Tafuri, Mario Tiribelli, Robin Foa, Giuseppe Saglio
BRITISH JOURNAL OF HAEMATOLOGY (2022)
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
Elena Genovese, Margherita Mirabile, Sebastiano Rontauroli, Stefano Sartini, Sebastian Fantini, Lara Tavernari, Monica Maccaferri, Paola Guglielmelli, Elisa Bianchi, Sandra Parenti, Chiara Carretta, Selene Mallia, Sara Castellano, Corrado Colasante, Manjola Balliu, Niccolo Bartalucci, Raffaele Palmieri, Tiziana Ottone, Barbara Mora, Leonardo Potenza, Francesco Passamonti, Maria Teresa Voso, Mario Luppi, Alessandro Maria Vannucchi, Enrico Tagliafico, Rossella Manfredini
ANTIOXIDANTS (2022)
Mastocytosis: Fertility and Pregnancy Management in a Rare Disease
Jacqueline Ferrari, Pietro Benvenuti, Elisa Bono, Nicolas Fiorelli, Chiara Elena
FRONTIERS IN ONCOLOGY (2022)
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations
Francesco Passamonti, Emanuele Nicastri, Alice Di Rocco, Attilio Guarini, Adalberto Ibatici, Stefano Luminari, Malgorzata Mikulska, Carlo Visco
HEMATOLOGICAL ONCOLOGY (2023)
Myelofibrosis
Francesco Passamonti, Barbara Mora
BLOOD (2023)
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naive Myelofibrosis
John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K. Rampal, Adam J. Mead, Gabriella Hobbs, Joseph M. Scandura, Moshe Talpaz, Nikki Granacher, Tim C. P. Somervaille, Ronald Hoffman, Marielle J. Wondergem, Mohamed E. Salama, Gozde Colak, Jike Cui, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Srdan Verstovsek, Natalia Curto-Garcia, Claire Harrison, Vikas Gupta
JOURNAL OF CLINICAL ONCOLOGY (2023)
Deciphering molecular complexity of HCV-associated lymphoproliferation
Michele Merli, Francesco Passamonti, Luca Arcaini
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Early treatment for COVID-19 in patients with haematological malignancies: Much more than a recommendation!
Francesco Passamonti, Alessandra Bandera
BRITISH JOURNAL OF HAEMATOLOGY (2023)
Survival expectation after thrombosis and overt-myelofibrosis in essential thrombocythemia and prefibrotic myelofibrosis: a multistate model approach
Alessandra Carobbio, Alessandro Maria Vannucchi, Elisa Rumi, Valerio De Stefano, Alessandro Rambaldi, Giuseppe Carli, Maria Luigia Randi, Heinz Gisslinger, Francesco Passamonti, Juergen Thiele, Naseema Gangat, Ayalew Tefferi, Tiziano Barbui
BLOOD CANCER JOURNAL (2023)
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study
Nicola Stefano Fracchiolla, Mariarita Sciume, Cristina Papayannidis, Antonella Vitale, Sabina Chiaretti, Mario Annunziata, Fabio Giglio, Prassede Salutari, Fabio Forghieri, Davide Lazzarotto, Monia Lunghi, Annalisa Imovilli, Barbara Scappini, Massimiliano Bonifacio, Michelina Dargenio, Carmela Gurrieri, Elisabetta Todisco, Marzia Defina, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Cerrano, Lidia Santoro, Elena Tagliaferri, Enrico Barozzi, Pasquale De Roberto, Marta Canzi, Elisa Buzzatti, Chiara Sartor, Francesco Passamonti, Robin Foa, Antonio Curti, Thomas Wirth
CANCERS (2023)
Real-world outcomes with fedratinib therapy in patients who discontinued ruxolitinib for primary myelofibrosis
Francesco Passamonti, Youbei Lou, Manoj Chevli, Pranav Abraham
FUTURE ONCOLOGY (2023)